Spinal cord injury and protection

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Traumatic spinal cord injury initiates a cascade of damaging pathophysiological events, including necrosis, ischemia, edema, and inflammation.
• These events involve significant alterations in cellular membranes, such as lipid peroxidation and hydrolysis, leading to the formation of vasoactive eicosanoids.

Purpose of the Study:

• To investigate the role of membrane lipid alterations in spinal cord injury pathophysiology.
• To explore the potential of various compounds with antioxidant and anti-lipid-hydrolysis properties in ameliorating spinal cord injury.

Main Methods:

• Review of existing studies on spinal cord injury and the effects of various therapeutic interventions.
• Analysis of the proposed mechanisms of action for compounds like methylprednisolone sodium succinate, vitamin E, selenium, DMSO, naloxone, and TRH.

Main Results:

• Posttraumatic events like ischemia, edema, and inflammation appear to be linked to extensive membrane peroxidative reactions and lipolysis.
• Several compounds, including methylprednisolone sodium succinate (MPSS) and antioxidants (vitamin E, selenium, DMSO), demonstrate effectiveness in experimental animal models.
• Most effective agents possess antioxidant and/or anti-lipid-hydrolysis properties, suggesting their efficacy stems from inhibiting membrane damage.

Conclusions:

• The effectiveness of therapeutic agents in spinal cord injury may be attributed to their ability to mitigate membrane peroxidative reactions and lipid hydrolysis.
• Early administration of these agents is crucial for achieving maximum therapeutic benefit in spinal cord injury treatment.